Skip Nav Destination
Issues
1 March 2008
-
Cover Image
Cover Image
H&E staining of a muscle-invasive KU-7 bladder tumor one month after orthotopic tumor cell inoculation in an untreated nude mouse demonstrating multifocal and aggressive disease. Magnification ×10 on a BLISS microscope imaging workstation. In contrast, bi-weekly intravesical chemotherapy with HTI-286 would have significantly delayed tumor growth. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
In Memoriam
Editorial
CCR Drug Update
Molecular Pathways
Report from the FDA
U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens
Ruthann M. Giusti; Kaushikkumar Shastri; Anne M. Pilaro; Chana Fuchs; Ruth Cordoba-Rodriguez; Kallappa Koti; Mark Rothmann; Angela Yuxin Men; Hong Zhao; Monica Hughes; Patricia Keegan; Karen D. Weiss; Richard Pazdur
Reviews
Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes
Raja R. Seethala; William E. Gooding; Phoebe N. Handler; Bobby Collins; Qing Zhang; Jill M. Siegfried; Jennifer R. Grandis
Human Cancer Biology
Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding
Barbara Belletti; Jayant S. Vaidya; Sara D'Andrea; Frank Entschladen; Mario Roncadin; Francesca Lovat; Stefania Berton; Tiziana Perin; Ezio Candiani; Sonia Reccanello; Andrea Veronesi; Vincenzo Canzonieri; Mauro G. Trovò; Kurt S. Zaenker; Alfonso Colombatti; Gustavo Baldassarre; Samuele Massarut
Imaging, Diagnosis, Prognosis
Vascular Imaging of Solid Tumors in Rats with a Radioactive Arsenic-Labeled Antibody that Binds Exposed Phosphatidylserine
Marc Jennewein; Matthew A. Lewis; Dawen Zhao; Edward Tsyganov; Nikolai Slavine; Jin He; Linda Watkins; Vikram D. Kodibagkar; Sean O'Kelly; Padmakar Kulkarni; Peter P. Antich; Alex Hermanne; Frank Rösch; Ralph P. Mason; Philip E. Thorpe
WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence
Biaoyang Lin; Angelita G. Utleg; Karsten Gravdal; James T. White; Ole J. Halvorsen; Wei Lu; Lawrence D. True; Robert Vessella; Paul H. Lange; Peter S. Nelson; Leroy Hood; Karl-Henning Kalland; Lars A. Akslen
Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma
Kazu Shiomi; Yoshiaki Hagiwara; Kouji Sonoue; Tatsuya Segawa; Kazuya Miyashita; Masahiro Maeda; Hiroshi Izumi; Kimihiko Masuda; Masataka Hirabayashi; Takao Moroboshi; Takashi Yoshiyama; Atsuko Ishida; Yuji Natori; Akira Inoue; Masashi Kobayashi; Yukinori Sakao; Hideaki Miyamoto; Kazuhisa Takahashi; Okio Hino
Cancer Therapy: Clinical
Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
Eyal C. Attar; Daniel J. DeAngelo; Jeffrey G. Supko; Ferdinando D'Amato; David Zahrieh; Andres Sirulnik; Martha Wadleigh; Karen K. Ballen; Steve McAfee; Kenneth B. Miller; James Levine; Ilene Galinsky; Elizabeth G. Trehu; David Schenkein; Donna Neuberg; Richard M. Stone; Philip C. Amrein
Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
Dan Laheru; Eric Lutz; James Burke; Barbara Biedrzycki; Sara Solt; Beth Onners; Irena Tartakovsky; John Nemunaitis; Dung Le; Elizabeth Sugar; Kristen Hege; Elizabeth Jaffee
Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer
Alberto A. Chiappori; Eric Haura; Francisco A. Rodriguez; David Boulware; Rachna Kapoor; Anthony M. Neuger; Richard Lush; Barbara Padilla; Michelle Burton; Charles Williams; George Simon; Scott Antonia; Daniel M. Sullivan; Gerold Bepler
Cancer Therapy: Preclinical
Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells
Peter C. Black; Gordon A. Brown; Teruo Inamoto; Marissa Shrader; Ameeta Arora; Arlene O. Siefker-Radtke; Liana Adam; Dan Theodorescu; Xifeng Wu; Mark F. Munsell; Menashe Bar-Eli; David J. McConkey; Colin P.N. Dinney
Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels
Myron S. Czuczman; Scott Olejniczak; Aruna Gowda; Adam Kotowski; Arvinder Binder; Harman Kaur; Joy Knight; Petr Starostik; Julie Deans; Francisco J. Hernandez-Ilizaliturri
Cancer Prevention and Susceptibility
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.